Table 1 Basic characteristics assessment of included literatures
Study year | Country | Surgery site | Experimental group | Control group | Prevention method | Study quality | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
n | Male/female | Age | n | Male/female | Age | Experimental group | Control group | Â | |||
Bi CQ 2009 [12] | China | Fracture and arthroplasty | 35 | 10\25 | 69.57 ± 9.84 | 35 | 7\28 | 66.71 ± 9.13 | On the basis of the control group, Yiqi Poxue traditional Chinese medicine | Low molecular weight heparin (LMWH) | RCT |
Chen CL 2014 [13] | China | Arthroplasty | 48 | 18\30 | 64.5 ± 15.6 | 48 | 12\36 | 61.7 ± 12.5 | On the basis of the control group, Taohong Siwu soup | Rivaroxaban | RCT |
Chen T 2016 [14] | China | Fracture | 45 | 24\21 | 60.6 ± 1.8 | 45 | 25\20 | 60.5 ±2.1 | On the basis of the control group, topical with traditional Chinese medicine | Low molecular weight heparin (LMWH), aspirin | RCT |
Ge XL 2007 [15] | China | Arthroplasty | 30 | – | 66.8 | 30 | – | 66.8 | On the basis of the control group, Ligustrazine hydrochloride | Low molecular weight heparin (LMWH) | RCT |
He Y 2013 [16] | China | Arthroplasty | 62 | – | 64 | 62 | – | 64 | On the basis of the control group, Yiqi Huoxue Huayu soup | Low molecular weight heparin (LMWH) | RCT |
Huang SX 2009 [17] | China | Fracture and arthroplasty | 60 | 35\25 | 58.6 | 60 | 38\22 | 56.2 | On the basis of the control group, Danshen injection liquid | Low molecular weight heparin (LMWH) | RCT |
Huang XG 2010 [18] | China | Arthroplasty | 31 | 11\20 | 58.46 | 32 | 9\23 | 55.72 | On the basis of the control group, Gubu soup | Low molecular weight heparin (LMWH) | RCT |
Jiang KW 2011 [19] | China | Arthroplasty | 65 | – | 66.4 | 73 | – | 66.4 | Chinese medicine decoction | Low molecular weight heparin (LMWH) | RCT |
Li DF 2015 [20] | China | Fracture and arthroplasty | 25 | 16\9 | 22–76 | 25 | 18\7 | 27–77 | On the basis of the control group, Huoxue Tongmai soup | Rivaroxaban | RCT |
Li JH 2015 [21] | China | fracture | 44 | – | 72±17 | 41 | – | 68±18 | Danggui Shaoyao powder | Low molecular weight heparin (LMWH) | RCT |
Lin X 2010 [22] | China | Arthroplasty | 40 | 25\15 | 78.15 ± 15.43 | 40 | 26\14 | 76.36 ± 14.37 | Buyang Huanwu soup | Aspirin | RCT |
Shao ZH 2016 [23] | China | Arthroplasty | 45 | 24\21 | 67.4 ± 5.1 | 45 | 23\22 | 66.6 ± 4.8 | On the basis of the control group, Danshen injection liquid, Taohong Siwu soup | Rivaroxaban | RCT |
Shi M 2011 [24] | China | Arthroplasty | 29 | 22\7 | 69.13 ± 7.89 | 34 | 23\11 | 67.49 ± 8.36 | Chinese medicine decoction | Low molecular weight heparin (LMWH) | RCT |
Wang XG 2017 [25] | China | Fracture and arthroplasty | 34 | 15\19 | 62.6 ± 5.81 | 34 | 16\18 | 63.4 ± 3.17 | On the basis of the control group, Tongmai Yiqi Chinese medicine decoction | Low molecular weight heparin (LMWH) | RCT |
Xiao G 2015 [26] | China | Fracture | 38 | – | – | 38 | – | – | On the basis of the control group, Chinese medicine decoction | Low molecular weight heparin (LMWH) | RCT |
Yuan SH 2009 [27] | China | Arthroplasty | 28 | 16\12 | 66.4 | 26 | 16\10 | 64.5 | On the basis of the control group, Shuxue Tongmai injection liquid | Low molecular weight heparin (LMWH) | RCT |
Zhai JB 2016 [28] | China | Fracture and arthroplasty | 38 | 18\20 | 64.5 ± 10.2 | 38 | 21\17 | 63.1 ± 10.8 | On the basis of the control group, Chinese medicine decoction self-made | Low molecular weight heparin (LMWH) | RCT |
Zhang FY 2009 [29] | China | Fracture and arthroplasty | 45 | 34\11 | 60 | 42 | 30\12 | 56 | On the basis of the control group, Danshen injection liquid | Low molecular weight heparin (LMWH) | RCT |
Zhao Q 2017 [30] | China | Fracture | 95 | 44\51 | 58.94 ± 7.02 | 95 | 47\48 | 58.96 ± 4.93 | On the basis of the control group, Huoxue Zhuyu Tongluo soup | Low molecular weight heparin (LMWH) | RCT |
Zhou ZQ 2010 [31] | China | Fracture and arthroplasty | 73 | 44\29 | 15–85 | 109 | 57\52 | 15–85 | Honghua injection liquid | Low molecular weight heparin (LMWH) | RCT |